ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2017. The put-call ratio across all filers is 2.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $19,000 | -73.6% | 13,721 | -1.7% | 0.00% | – |
| Q4 2021 | $72,000 | -15.3% | 13,960 | -2.7% | 0.00% | – |
| Q3 2021 | $85,000 | -7.6% | 14,353 | +25.5% | 0.00% | – |
| Q2 2021 | $92,000 | -72.0% | 11,434 | -26.9% | 0.00% | – |
| Q1 2019 | $329,000 | +103.1% | 15,638 | +10.7% | 0.00% | – |
| Q4 2018 | $162,000 | -58.8% | 14,129 | -17.6% | 0.00% | – |
| Q3 2018 | $393,000 | +37.9% | 17,143 | +34.0% | 0.00% | – |
| Q2 2018 | $285,000 | -56.0% | 12,797 | -55.6% | 0.00% | – |
| Q3 2017 | $647,000 | -46.2% | 28,837 | -50.2% | 0.00% | – |
| Q4 2016 | $1,203,000 | +23960.0% | 57,954 | +28732.8% | 0.00% | – |
| Q2 2015 | $5,000 | -100.0% | 201 | -100.0% | 0.00% | -100.0% |
| Q1 2014 | $12,663,000 | +132.9% | 580,613 | +43.2% | 0.01% | +150.0% |
| Q3 2013 | $5,438,000 | – | 405,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,067,560 | $53,364,000 | 28.19% |
| Selkirk Management LLC | 208,000 | $5,368,000 | 2.94% |
| Iguana Healthcare Management, LLC | 270,000 | $6,969,000 | 2.20% |
| Opaleye Management Inc. | 100,600 | $2,596,000 | 1.03% |
| Miura Global Management | 600,000 | $15,486,000 | 0.94% |
| DSC Advisors, L.P. | 57,400 | $1,481,000 | 0.77% |
| Cannell & Co. | 1,016,828 | $26,244,000 | 0.74% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $7,138,000 | 0.61% |
| Harvest Capital Strategies LLC | 100,000 | $2,581,000 | 0.33% |
| Raging Capital Management, LLC | 93,932 | $2,424,000 | 0.31% |